Adicet Bio Return On Equity vs. Net Income

ACET Stock  USD 1.01  0.09  8.18%   
Considering Adicet Bio's profitability and operating efficiency indicators, Adicet Bio may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Adicet Bio's ability to earn profits and add value for shareholders.
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
(0.84)
Current Value
(0.80)
Quarterly Volatility
0.41481814
 
Credit Downgrade
 
Yuan Drop
 
Covid
Price To Sales Ratio is likely to drop to 12.57 in 2024. Days Sales Outstanding is likely to drop to 5.43 in 2024. At this time, Adicet Bio's Accumulated Other Comprehensive Income is comparatively stable compared to the past year. Total Other Income Expense Net is likely to gain to about 9.8 M in 2024, despite the fact that Net Loss is likely to grow to (135.5 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.760.72
Notably Up
Slightly volatile
For Adicet Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Adicet Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Adicet Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Adicet Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Adicet Bio over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
For more information on how to buy Adicet Stock please use our How to Invest in Adicet Bio guide.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adicet Bio. If investors know Adicet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adicet Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.70)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.29)
Return On Equity
(0.58)
The market value of Adicet Bio is measured differently than its book value, which is the value of Adicet that is recorded on the company's balance sheet. Investors also form their own opinion of Adicet Bio's value that differs from its market value or its book value, called intrinsic value, which is Adicet Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adicet Bio's market value can be influenced by many factors that don't directly affect Adicet Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adicet Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adicet Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adicet Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Adicet Bio Net Income vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Adicet Bio's current stock value. Our valuation model uses many indicators to compare Adicet Bio value to that of its competitors to determine the firm's financial worth.
Adicet Bio is rated below average in return on equity category among its peers. It is rated below average in net income category among its peers . At this time, Adicet Bio's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Adicet Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Adicet Net Income vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Adicet Bio

Return On Equity

 = 

Net Income

Total Equity

 = 
-0.58
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Adicet Bio

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(142.66 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

Adicet Net Income Comparison

Adicet Bio is currently under evaluation in net income category among its peers.

Adicet Bio Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Adicet Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Adicet Bio will eventually generate negative long term returns. The profitability progress is the general direction of Adicet Bio's change in net profit over the period of time. It can combine multiple indicators of Adicet Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-152 M-144.4 M
Income Before Tax-142.7 M-135.5 M
Total Other Income Expense Net9.4 M9.8 M
Net Loss-142.7 M-135.5 M
Income Tax Expense5.9 M5.6 M
Net Interest Income10 M10.5 M
Interest Income10 M10.5 M
Net Loss-142.7 M-135.5 M
Net Loss(3.31)(3.15)
Income Quality 0.66  0.68 
Net Income Per E B T 0.86  0.61 

Adicet Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Adicet Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Adicet Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Adicet Bio's important profitability drivers and their relationship over time.

Use Adicet Bio in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adicet Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adicet Bio will appreciate offsetting losses from the drop in the long position's value.

Adicet Bio Pair Trading

Adicet Bio Pair Trading Analysis

The ability to find closely correlated positions to Adicet Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adicet Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adicet Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adicet Bio to buy it.
The correlation of Adicet Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adicet Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adicet Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adicet Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Adicet Bio position

In addition to having Adicet Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Obamacare Thematic Idea Now

Obamacare
Obamacare Theme
Health care services and providers including hospitals, clinics and nursing homes that hope to benefit from Obamacare program. The Obamacare theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Adicet Stock Analysis

When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.